WEEK FOUR FINAL PROJECT REVISIONS FOR WORD DOC AND POWERPOINT

SCM 640 Final Project Audit & Correction Guide

Supply Market Analysis: Healthcare & Pharmaceutical Cold-Chain Logistics

Purpose: identify rubric gaps, unsupported claims, citation/reference problems, presentation issues, and passages requiring authorship/AI review before submission.

1. Bottom Line: Do Not Submit the Current Version Yet

The report covers most required headings, but several of the most important quantitative and evaluative claims are unsupported by in-text citations.

The current document is only 13 pages total including title page, Executive Summary, Introduction, References, and all report content. The assignment requires 10–15 pages excluding the cover page, Executive Summary, Appendix, and References. Based on the supplied file, the body appears materially short of that requirement and should be expanded with substantive analysis rather than filler.

The PowerPoint repeats unsupported figures from the report ($20B+ market size, cost percentages, company revenues, and 8–12% growth) and contains no visible source citations or references slide.

The paper relies on only six references for a broad market analysis. Several reference entries are incomplete/generic and need to be verified against the actual sources used.

Grammarly's AI score is a warning signal, not proof. The stronger academic-integrity concern is that many factual claims, numbers, forecasts, and company assessments are presented without traceable sourcing.

2. Professor's Requirements vs. Current Submission

Rubric Area	Status	What to Fix	Priority
Executive Summary	Present	Needs stronger evidence linkage; recommendations appear before the report establishes sourced evidence.	MEDIUM
Introduction	Present	Contains only one visible in-text citation; temperature ranges and other factual statements need sources.	HIGH
Market Size	Present	$20B+ claim and regional leadership/growth claims are uncited.	CRITICAL
Trends	Present	Mostly descriptive lists. Needs sources and stronger explanation of why each trend changes transportation/distribution decisions.	HIGH
Cost Structure	Present	35/20/15/10/10/10 percentages have no identified source or methodology.	CRITICAL
Key Developments	Present	COVID, automation, acquisitions, resiliency claims need sourcing and concrete examples.	HIGH
3 Key Players	Present	Services/competitive advantages are largely uncited and need company/industry evidence.	HIGH
Financial Health	Present	Revenue numbers and qualitative ratings ('Excellent'/'Strong') need fiscal-year sources and explicit criteria.	CRITICAL
SWOT	Present	Too generic; needs evidence supporting major strengths/weaknesses/opportunities/threats.	HIGH
Porter's Five Forces	Present	Framework is present, but conclusions are asserted without evidence and should be tied to market facts.	HIGH
Industry Trends	Present	Overlaps earlier trends section; should synthesize implications rather than repeat.	MEDIUM
Price/Rate Outlook	Present	8–12% annual growth appears to describe market growth, not necessarily transportation rates; source and metric are unclear.	CRITICAL
Sourcing Recommendation	Present	Highest-value rubric area. Needs a transparent supplier comparison and evidence-based engage/avoid rationale.	CRITICAL
Conclusion	Present	Reasonable summary but repeats broad claims; should explicitly answer what the analysis proved.	MEDIUM
APA / Title / References	Weak	Title page is incomplete; references are incomplete; many claims lack in-text citations; URLs/DOIs/publication details may be missing.	CRITICAL
Grammar / Writing Style	Readable	Polished but formulaic/list-heavy. Needs more original synthesis, transitions, and team analysis.	HIGH

3. Highest-Priority Corrections

1 — Verify every number before rewriting anything

Market size: identify a credible source for the $20B+ figure and specify year, geographic scope, and market definition.

Cost structure: verify the 35%, 20%, 15%, 10%, 10%, 10% allocation. If no credible source supports it, remove the percentages or rebuild the table from sourced data.

Financial health: verify McKesson ~$360B, UPS ~$91B, and DHL ~$90B, use the correct fiscal year/currency, and cite the annual reports.

8–12% forecast: determine exactly what is growing 8–12% (market revenue? cold-chain logistics demand? transportation rates?) and cite the forecast. Do not call it a rate outlook unless the source actually forecasts rates.

2 — Add in-text citations throughout the report

Every market statistic, forecast, regulatory statement, temperature requirement, company revenue, service/capability claim, regional market claim, and externally derived trend should have a citation.

Do not rely on a References page alone. The reader must be able to connect each factual claim to its source.

When several sentences come from one source, cite where the source relationship is clear; do not leave entire pages of sourced facts uncited.

3 — Expand the body to meet the 10–15 page requirement

The professor excludes the cover page, Executive Summary, Appendix, and References from the 10–15 page count.

Add analysis, not padding: market segmentation, evidence behind trends, cost-driver explanation, financial metrics, comparative SWOT discussion, Five Forces evidence, rate drivers, and a supplier decision matrix.

Target roughly 10–12 full double-spaced body pages after exclusions so formatting changes do not accidentally push the paper below minimum.

4 — Strengthen the sourcing recommendation

This is the largest rubric category (13.75/55 points). Build a comparison matrix using criteria such as cold-chain capability, geographic reach, monitoring/visibility, regulatory expertise, financial health, specialty-pharma capability, resilience, and cost/rate position.

Explain why UPS/DHL/McKesson are recommended for different use cases. Avoid treating them as interchangeable suppliers.

For 'suppliers to avoid,' the assignment asks which companies should be avoided. If the team does not have evidence to name specific firms, explain that no named provider is rejected and instead establish disqualifying supplier criteria—confirm this interpretation with the instructor if necessary.

5 — Fix the PowerPoint as a sourced executive presentation

Add concise source footnotes to slides containing numbers, forecasts, regulations, and company-specific facts.

Add a final References slide.

Make the presentation tell the same evidence-based story as the corrected paper; update slides after the paper is corrected.

Keep slides visual, but be prepared to explain the methodology and source behind every chart and number.

4. Section-by-Section Audit of the Report

Executive Summary

Good: identifies the market, key providers, and recommendation.

Fix: after the body is corrected, rewrite this last so it summarizes verified findings rather than broad assertions.

Add 2–4 concrete findings (for example, verified market growth, major cost driver, strongest competitive force, and supplier-selection result).

Introduction

Keep the Novack transportation citation.

Add sources for 2–8°C vaccine storage and ultra-low-temperature examples; be precise because temperature requirements vary by product.

Clarify scope: healthcare/pharmaceutical cold-chain transportation and distribution, geography, and what counts as the market.

Market Size

Critical: $20B+ is uncited.

Critical: 'North America remains the largest' and 'Asia-Pacific is fastest-growing' need a market source.

Improve with a base-year market size, forecast year, CAGR, and regional context from a reputable market/industry source.

Industry Trends

Cite biologics growth, digital monitoring, cell/gene therapy logistics, sustainability, and regulatory developments.

Move beyond listing technologies: explain the transportation/distribution implication of each trend (capital cost, service requirements, risk, network design, or supplier selection).

Cost Structure

Critical: the percentage table is unsupported.

If the percentages are estimates created by the team, label them as an analytical estimate and explain the method/data. If not, replace them with sourced figures.

Explain fixed vs. variable cost drivers and why cold-chain costs differ from standard freight.

Key Developments

Use concrete examples and dates for vaccine distribution, warehouse automation, acquisitions, and resilience strategies.

For acquisitions, name actual transactions only after verifying them.

Connect each development to market structure, capacity, competition, or pricing.

Three Key Players

Cite each provider's healthcare services and capabilities.

Explain why each qualifies as a key player in the selected market.

Distinguish McKesson's distribution role from UPS/DHL's logistics/transportation roles; this matters to an apples-to-apples comparison.

Financial Health

Use actual annual-report figures with fiscal year, revenue currency, profitability/cash-flow or another relevant metric—not revenue alone.

Define the criteria for 'Excellent' and 'Strong.' Otherwise those labels are subjective.

Where healthcare-segment data are unavailable, state that limitation rather than implying company-wide revenue equals cold-chain revenue.

SWOT

Current SWOTs are very generic.

Add evidence for material weaknesses/threats and tie opportunities to sourced market trends.

Consider a table followed by comparative interpretation: which SWOT factors materially affect sourcing risk?

Porter's Five Forces

The five forces are correctly named, but the High/Moderate/Low ratings need evidence.

Support rivalry with named competitors/market concentration; entry barriers with compliance/capital requirements; buyer power with customer concentration/contract scale; supplier power with specialized inputs; substitutes with product requirements.

End with what the Five Forces analysis means for sourcing strategy.

Industry Trends & Price/Rate Outlook

Critical: 8–12% needs a source and metric definition.

Separate market-demand growth from freight/rate inflation. They are not the same thing.

Add actual rate drivers and, if credible data are available, a forecast range/time horizon. State uncertainty.

Sourcing Recommendations

This needs the most development because it carries the most rubric points.

Create a weighted or qualitative supplier scorecard and show how evidence leads to the recommendation.

Specify use cases: global cold-chain transport, pharmaceutical distribution, clinical-trial logistics, specialty handling, etc.

Explain tradeoffs, not only strengths.

Conclusion

Rewrite after all analysis is finalized.

State the 3–4 most defensible findings and the final sourcing decision.

Do not introduce new facts in the conclusion.

References / APA

Verify all six current references against the actual documents used.

The annual-report references need complete titles/publication details and retrievable source information as required by APA 7.

Verify whether the FDA and WHO titles listed are the exact titles of real documents/pages used; do not retain generic or AI-invented titles.

Every reference should be cited in text, and every in-text citation should have a matching reference entry.

Complete the student title page with student/team names, correct course number/name (SCM 640 Distribution Management), instructor, and date.

5. Claims That Need Immediate Source Verification

Claim	Location	What Must Be Verified	Action
Vaccines typically 2°C–8°C; some therapies as low as -80°C	Introduction	Product-specific temperature requirements; FDA/WHO/manufacturer or peer-reviewed source	Cite, qualify, or remove
Global market exceeds $20B	Market Size / PPT slide 3	Credible market/industry report with year and definition	Cite, qualify, or remove
North America largest; Asia-Pacific fastest-growing	Market Size / PPT slide 3	Same or another credible market report	Cite, qualify, or remove
Cost split: 35/20/15/10/10/10	Cost Structure / PPT slide 5	Original source or documented team methodology	Cite, qualify, or remove
Automation improves inventory accuracy/reduces errors	Key Developments	Industry/academic evidence	Cite, qualify, or remove
McKesson ~$360B; UPS ~$91B; DHL ~$90B	Financial Health / PPT slide 8	Each company's annual report; fiscal year and currency	Cite, qualify, or remove
Cell and gene therapies are among fastest-growing segments	Trends	Industry/peer-reviewed source	Cite, qualify, or remove
Rates expected to rise for next five years	Price/Rate Outlook	Rate-specific forecast source	Cite, qualify, or remove
8–12% expected annual growth	Price/Rate Outlook / PPT slide 11	Source + exact metric + forecast period	Cite, qualify, or remove

6. AI / Authorship Review: What to Focus On

Do not treat an AI-detector percentage as proof. Review the following patterns because they increase academic-integrity risk when the underlying sources or team reasoning cannot be demonstrated:

Highly uniform paragraph structure and repeated constructions such as 'Companies are increasingly...' / 'Organizations should...' without specific evidence.

Long sequences of polished factual claims with no citations.

Specific numbers or forecasts that appear without a traceable source.

Generic SWOT and Five Forces statements that could apply to many industries.

Reference entries that look plausible but are too generic to identify the actual source.

Claims that the team cannot explain orally, reproduce from a source, or defend with course concepts.

Sections completed by one person that do not match the assigned team workflow or cannot be traced to research notes.

Best correction approach: verify the research first, then have the responsible team member rewrite the analysis in their own words and add proper citations. Do not use an 'AI humanizer' merely to evade detection.

7. PowerPoint Audit

Slide 2 Executive Summary: clear but unsourced. Keep it concise and align it with the corrected paper.

Slide 3 Market Size: $20B+, North America leadership, and Asia-Pacific growth all need source footnotes.

Slide 4 Trends: add compact source footnotes and ensure regulatory acronyms are accurate and supported.

Slide 5 Cost Structure: do not present the percentage chart until its data source/methodology is verified.

Slide 6 Developments: add concrete, sourced examples where possible.

Slide 7 Key Players: cite company sources; make clear McKesson is a pharmaceutical distributor/integrator while UPS/DHL are logistics providers.

Slide 8 Financial Health: cite annual reports directly on the slide and identify fiscal year/currency. Explain rating criteria.

Slide 9 SWOT: visually strong, but evidence is thin. Presenter notes should contain support for major claims.

Slide 10 Five Forces: add evidence/source footnotes and one takeaway sentence explaining strategic meaning.

Slide 11 Price/Rate Outlook: highest-risk slide. The 8–12% figure must be verified and must not conflate market CAGR with transportation rate growth.

Slide 12 Sourcing Recommendations: strengthen with a supplier scorecard or decision criteria.

Slide 13 Conclusion: add a References slide after it; do not end without sources.

Add speaker notes or a team speaking outline so every member can explain their assigned analysis rather than reading slides.

8. Recommended Evidence Plan

Company evidence: McKesson, UPS, and DHL annual reports plus official healthcare/logistics capability pages.

Regulatory evidence: FDA, WHO, and IATA primary guidance where relevant.

Market evidence: at least 2 credible market/industry sources for size, CAGR, regional trends, and outlook; clearly state source definitions.

Academic/course evidence: use the Novack transportation text and, where useful, peer-reviewed or reputable industry research to support transportation concepts.

Aim for a stronger source base than the current six references. Quality matters more than an arbitrary count, but a market analysis this broad should not rest on six mostly general sources.

9. Final Pre-Submission Checklist

☐ Body is 10–15 pages after excluding cover page, Executive Summary, Appendix, and References.

☐ Title page has team names, National University, SCM 640 Distribution Management, instructor, and date.

☐ Every required rubric section is clearly labeled and substantively analyzed.

☐ All quantitative claims are verified and cited.

☐ All company-specific claims are cited.

☐ All regulatory/temperature claims are cited.

☐ Cost percentages are sourced or removed/rebuilt.

☐ Financial figures include fiscal year/currency and source.

☐ Financial-health rating method is explained.

☐ 8–12% figure is verified, correctly labeled, or removed.

☐ Sourcing recommendation uses explicit comparison criteria and evidence.

☐ Report has complete APA 7 in-text citations and references.

☐ Every reference is actually used; every citation has a matching reference.

☐ PowerPoint numbers match the final report.

☐ PowerPoint has slide-level citations and a References slide.

☐ Each team member reviews and can explain the final consolidated work.

☐ Run Turnitin before final submission and investigate each meaningful match; do not rely only on the similarity percentage.

☐ Run spelling/grammar check after substantive edits.

☐ Final group review confirms no unsupported or unverifiable content remains.

10. Suggested Order of Work

1. Freeze the current version as a baseline.

2. Verify every source and every quantitative claim.

3. Fix/expand the report section by section against the rubric.

4. Build the supplier comparison/scorecard and strengthen the sourcing recommendation.

5. Complete APA citations and reference list.

6. Rewrite the Executive Summary and Conclusion last.

7. Update the PowerPoint only after the report is final.

8. Add slide citations and a References slide.

9. Conduct a team read-through and oral-defense check: each member explains their assigned sections and the final recommendation.

10. Submit to Turnitin, review flagged overlap, make legitimate attribution/original-writing corrections, then submit the final version.

11. Overall Assessment

The project has a usable structure and covers the professor's required topic headings, but the current version is not yet submission-ready. The biggest risks are unsupported quantitative claims, inadequate in-text citation, incomplete/possibly generic references, insufficient body length under the professor's counting rule, and a sourcing recommendation that needs deeper comparative analysis. Correcting those items will do more for the grade and academic-integrity protection than trying to lower an AI-detector score.